IFI30
Basic information
Region (hg38): 19:18173162-18178117
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IFI30 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 2 | 1 |
Variants in IFI30
This is a list of pathogenic ClinVar variants found in the IFI30 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-18173891-TG-T | Likely benign (Mar 01, 2023) | |||
19-18173940-C-G | not specified | Uncertain significance (Jan 30, 2024) | ||
19-18175041-C-A | not specified | Uncertain significance (Jan 10, 2023) | ||
19-18175086-C-T | Benign (Jun 01, 2022) | |||
19-18175192-T-G | not specified | Uncertain significance (Nov 10, 2024) | ||
19-18175211-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
19-18175320-G-A | not specified | Uncertain significance (Jul 16, 2024) | ||
19-18175326-G-A | not specified | Uncertain significance (Aug 10, 2023) | ||
19-18175375-A-G | not specified | Uncertain significance (Aug 16, 2021) | ||
19-18175604-G-A | Uncertain significance (Sep 16, 2018) | |||
19-18175639-C-G | not specified | Uncertain significance (Sep 04, 2024) | ||
19-18175650-A-G | not specified | Uncertain significance (Jun 16, 2024) | ||
19-18175651-T-C | not specified | Uncertain significance (Jul 15, 2024) | ||
19-18175667-G-C | not specified | Uncertain significance (Mar 08, 2024) | ||
19-18175677-A-T | not specified | Uncertain significance (Oct 29, 2021) | ||
19-18177196-G-A | not specified | Uncertain significance (May 26, 2024) | ||
19-18177206-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
19-18177228-A-C | not specified | Uncertain significance (Apr 05, 2023) | ||
19-18177236-C-T | not specified | Uncertain significance (May 26, 2024) | ||
19-18177738-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
19-18177849-G-A | not specified | Uncertain significance (Sep 24, 2024) | ||
19-18177868-G-C | not specified | Uncertain significance (Aug 19, 2024) | ||
19-18177882-A-T | Likely benign (Sep 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IFI30 | protein_coding | protein_coding | ENST00000407280 | 7 | 4956 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.96e-8 | 0.175 | 124590 | 0 | 28 | 124618 | 0.000112 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.630 | 112 | 132 | 0.846 | 0.00000709 | 1566 |
Missense in Polyphen | 41 | 48.9 | 0.83845 | 571 | ||
Synonymous | -0.276 | 61 | 58.3 | 1.05 | 0.00000362 | 485 |
Loss of Function | 0.203 | 12 | 12.8 | 0.939 | 5.97e-7 | 139 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000264 | 0.000255 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000667 | 0.0000556 |
Finnish | 0.0000941 | 0.0000928 |
European (Non-Finnish) | 0.000140 | 0.000133 |
Middle Eastern | 0.0000667 | 0.0000556 |
South Asian | 0.0000656 | 0.0000654 |
Other | 0.000173 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Lysosomal thiol reductase that can reduce protein disulfide bonds. May facilitate the complete unfolding of proteins destined for lysosomal degradation. Plays an important role in antigen processing. Facilitates the generation of MHC class II- restricted epitodes from disulfide bond-containing antigen by the endocytic reduction of disulfide bonds (By similarity). Facilitates also MHC class I-restricted recognition of exogenous antigens containing disulfide bonds by CD8+ T-cells or crosspresentation (By similarity). {ECO:0000250}.;
- Pathway
- Antigen processing and presentation - Homo sapiens (human);Cytokine Signaling in Immune system;MHC class II antigen presentation;Immune System;Adaptive Immune System;Interferon gamma signaling;Interferon Signaling
(Consensus)
Intolerance Scores
- loftool
- 0.555
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.74
Haploinsufficiency Scores
- pHI
- 0.376
- hipred
- N
- hipred_score
- 0.153
- ghis
- 0.545
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.190
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ifi30
- Phenotype
- immune system phenotype;
Gene ontology
- Biological process
- antigen processing and presentation of exogenous peptide antigen via MHC class II;antigen processing and presentation of exogenous peptide antigen via MHC class I;oxidation-reduction process;interferon-gamma-mediated signaling pathway
- Cellular component
- extracellular region;lysosome;cytosol;cell junction;lysosomal lumen;intracellular membrane-bounded organelle
- Molecular function
- protein binding;oxidoreductase activity, acting on a sulfur group of donors